therapeutics – Investor Holding

Jasper Therapeutics beats Q2 expectations but shares fall after results

August 17, 2026

Jasper Therapeutics Inc. (NASDAQ:JSPR), a clinical-stage biotechnology firm, announced second-quarter 2026 financial results on Monday, August 17, 2026, surpassing analyst expectations for its adjusted loss per share. Despite the positive…

Stock Market & Trading

AstraZeneca Forges Landmark $1.77 Billion Partnership with CSPC Pharmaceutical Group for Kidney Disease Therapeutics

July 2, 2026

AstraZeneca PLC (AZN), a global biopharmaceutical giant, has solidified a significant strategic partnership with CSPC Pharmaceutical Group Limited (CSPCY), one of China’s leading pharmaceutical companies, for the development and commercialization…

Jasper Therapeutics beats Q2 expectations but shares fall after results

You missed

Rural Microtransit Programs Reshape Transportation Landscapes by Bridging Essential Service Gaps for Remote Populations

Jasper Therapeutics beats Q2 expectations but shares fall after results

OpenAI President Greg Brockman Dismisses Concerns Over Executive Departures Amid Rapid Organizational Scaling

Industry Leaders Unveil New Platform for Enhanced Market Insights and Engagement

Tag: therapeutics

Jasper Therapeutics beats Q2 expectations but shares fall after results

AstraZeneca Forges Landmark $1.77 Billion Partnership with CSPC Pharmaceutical Group for Kidney Disease Therapeutics

You missed

Rural Microtransit Programs Reshape Transportation Landscapes by Bridging Essential Service Gaps for Remote Populations

Jasper Therapeutics beats Q2 expectations but shares fall after results

OpenAI President Greg Brockman Dismisses Concerns Over Executive Departures Amid Rapid Organizational Scaling

Industry Leaders Unveil New Platform for Enhanced Market Insights and Engagement